Kyle Kuvalanka
Director/Board Member at IMV INC.
Net worth: - $ as of 2023-12-30
Kyle Kuvalanka active positions
| Companies | Position | Start | End |
|---|---|---|---|
| IMV INC. | Director/Board Member | 2021-03-31 | - |
| Independent Dir/Board Member | 2021-03-31 | - | |
Rome Therapeutics, Inc.
 Rome Therapeutics, Inc. BiotechnologyHealth Technology Rome Therapeutics, Inc. develops novel therapies for cancer and autoimmune diseases by harnessing the power of the repeatome-vast stretches of uncharted genetic materials. The company was founded by Rosana Kapeller and is headquartered in Cambridge, MA. | Director of Finance/CFO | 2023-10-03 | - |
| Corporate Officer/Principal | 2023-10-03 | - |
Career history of Kyle Kuvalanka
Former positions of Kyle Kuvalanka
| Companies | Position | Start | End |
|---|---|---|---|
| SYROS PHARMACEUTICALS, INC. | Comptroller/Controller/Auditor | 2015-09-20 | 2017-09-21 |
| Chief Operating Officer | 2015-09-20 | 2017-09-21 | |
| Director of Finance/CFO | 2015-09-20 | 2017-09-21 | |
| BLUEPRINT MEDICINES CORPORATION | Comptroller/Controller/Auditor | 2013-08-31 | 2015-09-17 |
| Director of Finance/CFO | 2013-08-31 | 2015-09-17 | |
| Treasurer | 2013-08-31 | 2015-09-17 | |
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | 2008-12-31 | 2013-08-31 |
Goldfinch Bio, Inc.
 Goldfinch Bio, Inc. Pharmaceuticals: MajorHealth Technology Goldfinch Bio, Inc. operates as a biotechnology company. It focuses on discovering and developing precision therapies for patients with kidney disease. The firm develops and manufactures medicines. The company was founded by Joseph Vincent Bonventre, Anna Greka, Fridhelm Hildebrandt, Daniel MacArthur, Stefan Somlo and Peter Mundel in December 2016 and is headquartered in Cambridge, MA. | Chief Operating Officer | 2020-03-31 | - |
| Director of Finance/CFO | 2020-03-31 | - |
Training of Kyle Kuvalanka
| Wesleyan University | Undergraduate Degree |
| The Wharton School of the University of Pennsylvania | Masters Business Admin |
Statistics
International
| United States | 8 |
| Canada | 2 |
Operational
| Director of Finance/CFO | 4 |
| Corporate Officer/Principal | 2 |
| Comptroller/Controller/Auditor | 2 |
Sectoral
| Health Technology | 7 |
| Consumer Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 3 |
|---|---|
| BLUEPRINT MEDICINES CORPORATION | Health Technology |
| SYROS PHARMACEUTICALS, INC. | Health Technology |
| IMV INC. | Health Technology |
| Private companies | 3 |
|---|---|
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Health Technology |
Goldfinch Bio, Inc.
Goldfinch Bio, Inc. Pharmaceuticals: MajorHealth Technology Goldfinch Bio, Inc. operates as a biotechnology company. It focuses on discovering and developing precision therapies for patients with kidney disease. The firm develops and manufactures medicines. The company was founded by Joseph Vincent Bonventre, Anna Greka, Fridhelm Hildebrandt, Daniel MacArthur, Stefan Somlo and Peter Mundel in December 2016 and is headquartered in Cambridge, MA. | Health Technology |
Rome Therapeutics, Inc.
Rome Therapeutics, Inc. BiotechnologyHealth Technology Rome Therapeutics, Inc. develops novel therapies for cancer and autoimmune diseases by harnessing the power of the repeatome-vast stretches of uncharted genetic materials. The company was founded by Rosana Kapeller and is headquartered in Cambridge, MA. | Health Technology |
- Stock Market
- Insiders
- Kyle Kuvalanka
- Experience
